Our investment in Basil Systems: Surfacing Regulatory Intelligence for Medtech and Pharma

bertamato
Golden Ventures
Published in
2 min readMar 16, 2021
Basil Systems announced their 1.5M seed funding today, co-led by Golden Ventures and Looking Glass Capital.

The past year has shown the world how vital it is to our collective global health to have a life science industry that can move with speed and precision. However, in most cases of medical device and drug development, accessing the regulatory related information that allows for an efficient go-to-market is always a struggle. There has been no single source of regulatory, discovery, application, clinical, and event data for MedTech and Pharma, not until Basil Systems.

When we were introduced to Basil, we immediately recognized the value of their product. Basil is leveraging AI and comprehensive data for MedTech and Pharma companies by providing analytics and insights that guide strategic product development decisions, improve product and supply chains, mitigate recall risks, and significantly increase regulatory approval rates.

It can’t be understated what this step-change means to MedTech and Pharma companies. They would otherwise spend significant time and resources to find this information, it can now be accessed easily, critically changing the outcome and trajectory of products in development. Already MedTech and Pharma companies in the US spend an estimated $42 billion a year on regulatory activities. With Basil, these efforts can be more comprehensive and address the regulatory landscape dynamically.

Basil brings together a team of life science industry experts and world class engineers to tackle this massive problem. Ross, the CCO, has worked in MedTech consulting for over 15 years. Mitch, Basil’s Chief Architect, has deep expertise in NLP and joins from Roblox. Anthony is an entrepreneur many times over and sold Co3 to IBM in 2016. Several team members have the shared experience of working at Anthony’s prior company and have come together again under Anthony’s leadership to build something massive.

We believe strongly that advances in AI for life science are a fundamental part of health outcomes and that companies like BenchSci, ProteinQure, and now Basil Systems are leading that future. We are proud to be supporting Anthony and the Basil team on this journey.

Basil is growing rapidly and is hiring in several areas. If you’re a backend or frontend engineer and want to help bring life-saving technology to market faster, we invite you to get in touch with Anthony.

Want Golden updates delivered? Sign up for our newsletter below.

--

--